| 영문 | advanced cancer | 한글 | 진행암 |
|---|---|---|---|
| 설명 | 조기암에 대한 말로 암의 경과가 진행된 것을 말한다. |
||
| FDP(s) | 1) Fibrinolytic split Products(= FSP) 2) Fibrinogen Degradation Products |
|---|---|
| FSP | familial spastic paraplegia; fibrin split products; fibrinogen split products; fine suspended partic... |
| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
| EE | embryo extract; end-to-end; end expiration; energy expenditure; Enterobacteriaceae enrichment [broth... |
| AGE | acrylamide gel; acute gastroenteritis; advanced glycation end product; agarose gel electrophoresis; ... |
| AGE | Advanced Glycation End Products |
|---|---|
| AGE | Advanced Glycosylated End-products |
| AGE | Advanced Glycosylation Endproducts |
| CDG | Congenital Disorders of Glycosylation |
| glycation | Glycosylation |
| glycosylation end products, advanced | Products derived from the nonenzymatic reaction of glucose and proteins in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of diabetes mellitus. (12 Dec 1998) |
|---|
| glycosylation | <biochemistry> The process of adding sugar units such as in the addition of glycan chains to proteins. (18 Nov 1997) |
|---|---|
| end-to-end bite | An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion. Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion. (05 Mar 2000) |
| end-to-end occlusion | An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion. Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion. (05 Mar 2000) |
| advanced concepts torus i | <physics> A steady-state toroidal device built primarily for studies of RF heating and RF current drive. Acronym: ACT I (09 Oct 1997) |
| advanced fuels | <radiobiology> There are several elements or isotopes that could be fused together, besides the DT fuel mixture. Many such fuel combinations would have various advantages over DT, but it is generally more difficult to achieve fusion with these advanced fuels than with the DT mix. (09 Oct 1997) |
| advanced life support | Definitive emergency medical care that includes defibrillation, airway management, and use of drugs and medications. Compare: basic life support. (05 Mar 2000) |
| advanced multiple-beam equalization radiography | A variant of scanning equalization radiography using several X-ray beams. (05 Mar 2000) |
| advanced toroidal facility | <physics> A large stellarator device developed at Oak Ridge National Lab (ORNL), but now retired. Acronym: ATF (09 Oct 1997) |
| integrated advanced information management systems | A concept, developed in 1983 under the aegis of and supported by the national library of medicine under the name of integrated academic information management systems, to provide professionals in academic health sciences centres and health sciences institutions with convenient access to an integrated and comprehensive network of knowledge. It addresses a wide cross-section of users from administrators and faculty to students and clinicians and has applications to planning, clinical and managerial decision-making, teaching, and research. It provides access to various types of clinical, management, educational, etc., databases, as well as to research and bibliographic databases. In august 1992 the name was changed from integrated academic information management systems to integrated advanced information management systems to reflect use beyond the academic milieu. (12 Dec 1998) |
| biological products | Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease (as vaccines or pollen extracts). Biological products are differentiated from biological factors in that the latter are compounds with biological or physiological activity made by living organisms. (12 Dec 1998) |
| blood products | Biopharmaceutical products purified from human blood, such as the blood clotting factor VIII used to treat haemophiliacs. (Recombinant factor VIII is also on the market.) The term also refers to biopharmaceuticals that act on blood or the cells that make blood. These products are often produced by the cells themselves, but in such tiny amounts that extracting them from blood is impractical, and so they are genetically engineered. (14 Nov 1997) |
| gene products, env | Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesised as protein precursors (polyproteins) and later cleaved into the final products by a viral protease. (12 Dec 1998) |
| gene products, gag | Proteins coded by the retroviral gag gene. The products are usually synthesised as protein precursors or polyproteins, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. Gag is short for group-specific antigen. (12 Dec 1998) |
| gene products, nef | Products of the HIV nef gene (formerly 3'-orf gene). The products trans-suppress viral replication and function as negative regulators of transcription. Nef stands for negative factor. (12 Dec 1998) |
| gene products, pol | Retroviral proteins coded by the pol gene. Often synthesised as a gag-pol fusion protein (fusion proteins, gag-pol) and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Pol is short for polymerase, the enzyme class of reverse transcriptase. (12 Dec 1998) |
Synonyms : Advanced Glycation End Products, Advanced Glycosylation End Products
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|